GPC3 CAR-T

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3 CAR-T, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) [Phase 1]

See pricing